DISCOVERY STARTS HERE

Philadelphia is the birthplace of cell and gene science.

CVIcon4.png
CVIcon1.png
CVIcon2.png
CVIcon3.png
CityVector.png

Budd Bioworks will be the end-to-end solution for commercialization of life changing cures produced in Philadelphia, advancing discoveries from clinical phase up to commercial scale manufacturing. 

INDUSTRY

INDUSTRY

Philadelphia has a 
rapidly expanding drug
development scene

The Greater Philadelphia region saw an almost 500 percent increase in venture capital funding in the last 18 months and has six FDA approved therapies with research origins from the region. 

40

CGT R&D Companies

$1.35B

Investment Capital for Life Sciences in First Half of 2021

CVImage_1.png

MEDIA

Claire Marrazzo Greenwood

Executive Director, CEO Council for Growth
Chamber of Commerce for Greater Philadelphia

We have so many of the elements already in place here in Philadelphia. We have the expertise, we have the deep science, we have a labor pool that is already primed and large enough, we are a low-cost market relative to other places, we are accessible to patients and customer base both in Europe and domestically in the United States. We know our international airport is already an asset and that it is further developing cargo capacity and cold storage. I'm pleased this all makes Philadelphia a really competitive choice.

DISCOVERY PIPELINE

PHILADELPHIA BIOCLUSTER

457
Discovery

Compounds1.png
Compounds2.png

322
Pre-Clinical

Compounds3.png

121
Phase I

89
Phase I/II

Compounds4.png

140
Phase II

Compounds4.png

7
Phase II/III

Compounds6.png
Compounds7.png

38
Phase III

COMPOUNDS IN DEVELOPMENT

1,174

TALENT

Philadelphia is a hub for biomedical
professionals

Philadelphia is a historic pharma center, home to 15 hospitals and a number of prestigious research universities. Currently 41% of Philadelphia's economy is directly or indirectly supported by the eds and meds sector - and growing.

 

The challenges of availability for both PhD level and biomanufacturing tech roles can be met in population dense Philadelphia which enjoys lower cost of living than other bioclusters.

70K

Employed in Life Sciences Regionally 

5,600

Biomedical Graduates 
in 2020

CVImage_2.jpg
AdobeStock_246155607.jpeg

Smart Choice

Our cluster is built on a solid foundation, supported by several renowned academic research institutions and hospitals:

Logo_Penn.png
CHOP.png
Logo_Jefferson.png
Logo_Temple.png
Wistar.png
Logo_Drexel.png

MEDIA

Sam Woods Thomas

Director of Life Sciences and Biotechnology
City of Philadelphia

Philly has what a lot of other major life science cities have, we have the talent, we have the institutions, we have the company base...what makes us really unique is that when considered against our peer cities like, New York and Boston, is that we actually have room to grow. Our offices, the mayor's office, the entire City of Philadelphia is 100% determined to see that life sciences has the opportunity to grow here and companies feel comfortable and can feel accommodated coming here.

PROXIMITY

Philadelphia is connected

The Philadelphia biocluster is a prime location to connect to patient populations, academic research and a bustling drug development scene. Between New York and Washington D.C., connect to 40 million consumers within hours via an efficient interstate road network. Our top tier international airport with advanced air cargo and cold storage capability puts the world at your reach.

Physician Stock.jpg
voo-qqq-RSYBi_1fhfM-unsplash.jpg